|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-7-19
|
|
pubmed:abstractText |
To assess interobserver variation in the diagnosis of dysplasia in Barrett's oesophagus, especially indefinite dysplasia (IND) using the revised Vienna classification. A secondary aim was to study clinical outcome of IND cases and to evaluate expression of alpha-methyl-CoA racemase (AMACR) as a marker predictive of progression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1365-2559
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
900-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20636793-Adenocarcinoma,
pubmed-meshheading:20636793-Adult,
pubmed-meshheading:20636793-Aged,
pubmed-meshheading:20636793-Aged, 80 and over,
pubmed-meshheading:20636793-Barrett Esophagus,
pubmed-meshheading:20636793-Disease Progression,
pubmed-meshheading:20636793-Esophageal Neoplasms,
pubmed-meshheading:20636793-Female,
pubmed-meshheading:20636793-Humans,
pubmed-meshheading:20636793-Hyperplasia,
pubmed-meshheading:20636793-Immunohistochemistry,
pubmed-meshheading:20636793-Male,
pubmed-meshheading:20636793-Middle Aged,
pubmed-meshheading:20636793-Observer Variation,
pubmed-meshheading:20636793-Precancerous Conditions,
pubmed-meshheading:20636793-Racemases and Epimerases
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
|
|
pubmed:affiliation |
Calderdale and Huddersfield NHS Trust, Leeds, UK. sunil.sonwalkar@cht.nhs.uk
|
|
pubmed:publicationType |
Journal Article
|
